Search Results
Mar 17, 2026, 03:54 ET Doceree Builds Strategic Growth Team with Paresh Rajpurohit and Andreas Tsitsos, Accelerates M&A Focus
capabilities."Paresh's experience across corporate development and strategic transactions makes him a valuable addition to the Doceree team," said Harshit Jain, MD, Founder & Global CEO of Doceree. "As Doceree continues its strong growth trajectory, we are focused not only on scaling the business, but
More news about: Doceree Inc.
Mar 16, 2026, 18:36 ET /C O R R E C T I O N -- Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments/
Association Georges C. Benjamin, MD. He adds, "Trust occurs when we engage the public in a transparent process, not one where decisions are made behind closed doors by unqualified individuals and presented in a disingenuous way." Ronald G. Nahass, MD, MHCM, FIDSA, President, IDSA:
Mar 16, 2026, 16:38 ET REMAX NATIONAL HOUSING REPORT FOR FEBRUARY 2026
-37.5 %Baltimore, MD2,598
More news about: RE/MAX, LLC
Mar 16, 2026, 16:30 ET AtkinsRéalis Collaborates with NVIDIA to Accelerate Deployment of Nuclear‑Powered AI Factories
these forward-looking statements. Those risks are identified in the 2025 MD&A (particularly in the section entitled "Risk and Uncertainties"), as may be updated from time to time in the Company's interim quarterly MD&A, are not exhaustive. The forward-looking statements herein reflect the Company's
More news about: AtkinsRéalis
Mar 16, 2026, 16:30 ET AtkinsRéalis Collaborates with NVIDIA to Accelerate Deployment of Nuclear‑Powered AI Factories
these forward-looking statements. Those risks are identified in the 2025 MD&A (particularly in the section entitled "Risk and Uncertainties"), as may be updated from time to time in the Company's interim quarterly MD&A, are not exhaustive. The forward-looking statements herein reflect the Company's
More news about: AtkinsRéalis
Mar 16, 2026, 16:23 ET Saul Centers Declares Quarterly Dividends
BETHESDA, Md., March 16, 2026 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS) has declared a quarterly dividend of $0.59 per share on its common stock, to be paid on April 30, 2026, to holders of record on April 15, 2026. The
More news about: Saul Centers, Inc.
Mar 16, 2026, 16:15 ET Hycroft Extends High-Grade Silver at Brimstone
high-grade silver system targeting the fluid pathway and stockwork veining. The holes were drilled in a zone between the east-west trending structures (MD_AD and Nicholes faults) in close proximity to the IP anomaly. All three holes showed strong geochemical signatures, silver mineralization, and stockwork
More news about: Hycroft Mining Holding Corporation
Mar 16, 2026, 16:05 ET Federal Realty Acquires Congressional North Shopping Center in Montgomery County, Maryland
Acquisition expands Federal Realty's control along the Region's Most Dominant Retail CorridorNORTH BETHESDA, Md., March 16, 2026 /PRNewswire/ --
More news about: Federal Realty Investment Trust
Mar 16, 2026, 15:59 ET American Society for Preventive Cardiology Announces 2026 Virtual Imaging Symposium Focused on Multimodality Cardiovascular Imaging for Prevention
Bailey, MD, FASPC, Leandro Slipczuk, MD, PhD, FASPC, Michael Blaha, MD, MPH, Khurram Nasir, MD, MPH, MSc, FASPC, Parag Joshi, MD, MHS, Leslee Shaw, PhD, Matt Budoff, MD, Deepak L. Bhatt, MD, MPH, FASPC, Seamus Whelton, MD, MPH, Valentin Fuster, MD, PhD, Borja Ibanez, MD, PhD, Beatriz López-Melgar, MD, PhD,
More news about: The American Society for Preventive Cardiology
Mar 16, 2026, 13:57 ET Egret Therapeutics Signs Memorandum of Understanding with Genexine Toward Full Ownership of Lead PD-1 Agonist Asset GX-P1 (EGT-101)
interest in its lead asset, GX-P1 (also known as EGT-101). "Securing full ownership of EGT-101 is a defining moment for Egret," said Daniel Chai, MD, Co-Founder and CEO of Egret Therapeutics. "By consolidating the intellectual property for this first-in-class PD-1 agonist, we gain the strategic autonomy
More news about: Turret Capital Management
Mar 16, 2026, 13:14 ET Vorbeck Materials Named Gold Sponsor of the Congressional Fire Services Institute
Market - the First PFAS-Free, UL 162-Listed Firefighting Foam to Beat Legacy AFFF Performance.COLUMBIA, Md., March 16, 2026 /PRNewswire/ -- Vorbeck Materials today announced its Gold Sponsorship of the Congressional Fire
More news about: Vorbeck Materials
Mar 16, 2026, 11:33 ET JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity
Cudkowicz, MD, MSc (Mass General Brigham and Harvard Medical School), Vivian Drory, MD (Tel-Aviv Sourasky Medical Centre), Adriano Chiò, MD, PhD (University of Torino), Christian Lunetta, MD (IRCCS Maugeri), Christen Shoesmith, MD (London Health Sciences Centre), Ruben van Eijk, MD, PhD
More news about: NeuroSense
Mar 16, 2026, 11:29 ET Renowned Orthopedic Spine Surgeon Dr. David Matusz Joins Dr. Sean McCance's Practice in New York City
Spine Associates of NYC (Manhattan), is pleased to announce that David M. Matusz MD, has joined the practice. Dr. Matusz is a very highly regarded orthopedic spine surgeon and Castle Connolly Top Doctor. The addition of Dr. Matusz further
More news about: Spine Associates of NYC
Mar 16, 2026, 09:38 ET Field Medical ernennt Mark A. Turco, MD, zum Vorstandsvorsitzenden
Generation der gepulsten Feldablation (PFA) für komplexe ventrikuläre und atriale Arrhythmien entwickelt, gab heute die Ernennung von Mark A. Turco, MD, zum Chief Executive Officer mit sofortiger Wirkung bekannt.
More news about: Field Medical, Inc.
Mar 16, 2026, 09:38 ET Field Medical nombra a Mark A. Turco, MD, como consejero delegado
campo pulsado (PFA) de segunda generación para arritmias ventriculares y auriculares complejas, ha anunciado hoy el nombramiento del Dr. Mark A. Turco, MD, como consejero delegado, con efecto inmediato.
More news about: Field Medical, Inc.
Mar 16, 2026, 09:38 ET Field Medical Names Mark A. Turco, MD, as Chief Executive Officer
second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.
More news about: Field Medical, Inc.
Mar 16, 2026, 09:38 ET Field Medical Names Mark A. Turco, MD, as Chief Executive Officer
second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.
More news about: Field Medical, Inc.
Mar 16, 2026, 09:38 ET Field Medical nomme Mark A. Turco, MD, au poste de directeur général
pulsé (PFA) de deuxième génération pour les arythmies ventriculaires et auriculaires complexes, a annoncé aujourd'hui la nomination de Mark A. Turco, MD, au poste de directeur général, à compter d'aujourd'hui.
More news about: Field Medical, Inc.
Mar 16, 2026, 09:23 ET Florida Cancer Specialists & Research Institute Expands Team of Cancer Experts in Lee County
Welcomes Xin Yao, MD to Statewide PracticeFORT MYERS, Fla., March 16, 2026 /PRNewswire/ --
More news about: Florida Cancer Specialists & Research Institute
Mar 16, 2026, 09:00 ET Understood Care Raises $8.4M to Scale AI-Native Infrastructure Layer for Patient Advocacy
personalized advocacy at scale."I've seen the urgent need for patient advocacy infrastructure first-hand as an ER physician," said Farzad Soleimani, MD, Healthcare Partner at 1984 Ventures. "Understood Care is tackling a massive, underserved market with an AI-native solution that genuinely improves people's
More news about: Understood Care
Mar 16, 2026, 08:01 ET Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome
the foundational research that led to the development of Progerinin, and we are happy to see this potential path moving forward," said Leslie Gordon, MD, PhD, Medical Director at Progeria Research Foundation. "PRF's mission is to find treatments and the cure for Progeria, and we are grateful for the efforts
More news about: Sentynl Therapeutics
Mar 16, 2026, 08:00 ET Choice Hotel International's Ascend Collection Surpasses 500 Hotel Openings, Marking a Major Achievement for the Company's Growth in Upscale
NORTH BETHESDA, Md., March 16, 2026 /PRNewswire/ -- Ascend Collection, an upscale soft brand of Choice Hotels International, Inc.
More news about: Choice Hotels International, Inc.
Mar 16, 2026, 07:30 ET DIAMONDROCK HOSPITALITY ANNOUNCES FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
BETHESDA, Md., March 16, 2026 /PRNewswire/ -- DiamondRock Hospitality Company (the "Company") will report financial results for the first quarter 2026 after the market closes on Thursday, April 30, 2026. The Company will hold
More news about: DiamondRock Hospitality Company
Mar 16, 2026, 07:00 ET Bell AI Fabric Expands National Network with 300 MW Data Centre in Saskatchewan
of risk factors is not exhaustive and other factors could also adversely affect our results. We encourage investors to also read BCE's 2025 Annual MD&A dated March 5, 2026 and BCE's press releases dated October 14, 2025 and February 5, 2026 with respect to BCE's 2025-2028 and 2026 financial guidance,
More news about: Bell Canada (MTL)
Mar 16, 2026, 07:00 ET Bell AI Fabric Expands National Network with 300 MW Data Centre in Saskatchewan
of risk factors is not exhaustive and other factors could also adversely affect our results. We encourage investors to also read BCE's 2025 Annual MD&A dated March 5, 2026 and BCE's press releases dated October 14, 2025 and February 5, 2026 with respect to BCE's 2025-2028 and 2026 financial guidance,
More news about: Bell Canada (MTL)